Table of Content




1. Executive Summary


2. Global Chronic Kidney Disease Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Chronic Kidney Disease Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Chronic Kidney Disease Market by Treatment
3.3.1: Drugs
3.3.2: Dialysis

3.4: Global Chronic Kidney Disease Market by End Use
3.4.1: Hospital
3.4.2: Dialysis Center
3.4.3: Others






4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Chronic Kidney Disease Market by Region
4.2: North American Chronic Kidney Disease Market
4.2.2: North American Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others


4.3: European Chronic Kidney Disease Market
4.3.1: European Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
4.3.2: European Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others


4.4: APAC Chronic Kidney Disease Market
4.4.1: APAC Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
4.4.2: APAC Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others


4.5: ROW Chronic Kidney Disease Market
4.5.1: ROW Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
4.5.2: ROW Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Chronic Kidney Disease Market by Treatment
6.1.2: Growth Opportunities for the Global Chronic Kidney Disease Market by End Use

6.1.3: Growth Opportunities for the Global Chronic Kidney Disease Market by Region

6.2: Emerging Trends in the Global Chronic Kidney Disease Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Chronic Kidney Disease Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chronic Kidney Disease Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Baxter International
7.2: Teva Pharmaceutical Industries
7.3: AstraZeneca
7.4: Johnson & Johnson
7.5: AbbVie
7.6: Becton
7.7: Dickinson and Company
7.8: B. Braun
7.9: F. Hoffmann-La Roche
7.10: Pfizer